Avner Schlessinger

Search results

• Reports on Drug Research from Icahn School of Medicine at Mount Sinai Provide New Insights (Describing Inhibitor Specificity for the Amino Acid Transporter Lat1 From Metainference Simulations)

  Keino Hutchinson & Avner Schlessinger

  13/02/23

  1 item of Media coverage

  Press/Media

• US Patent Issued to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI on Jan. 10 for "Kinase inhibitor compounds and compositions and methods of use" (New York Inventors)

  Robert DeVita, Avner Schlessinger & Andrew Stewart

  23/01/23

  1 item of Media coverage

  Press/Media

• Kinase Inhibitor Compounds and Compositions and Methods of Use

  Robert DeVita, Avner Schlessinger & Andrew Stewart

  10/01/23

  1 item of Media coverage

  Press/Media

• NIH-FUNDED WORK MAY LEAD TO CANCER TREATMENTS

  Avner Schlessinger

  23/11/20

  1 item of Media coverage

  Press/Media

• Researchers Discover a Novel Potassium Channel Activator Which Acts as a Potential Anticonvulsant

  Avner Schlessinger & Paul Slesinger

  30/06/20

  1 item of Media coverage

  Press/Media

• Novel potassium channel activator which acts as a potential anticonvulsant discovered

  Avner Schlessinger & Paul Slesinger

  30/06/20

  4 items of Media coverage

  Press/Media

• Australia Patent: Yale University, Icahn School of Medicine at Mount Sinai File Application for 'Compositions and methods for treating or preventing endocrine FGF23-linked diseases'

  Avner Schlessinger

  26/06/20

  1 item of Media coverage

  Press/Media

• WIPO PUBLISHES PATENT OF YALE UNIVERSITY AND ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI FOR "COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ENDOCRINE FGF23-LINKED DISEASES" (AMERICAN INVENTORS)

  Avner Schlessinger

  26/06/19

  1 item of Media coverage

  Press/Media

• CURING CANCER: ALLEN THOMAS AIMS TO BETTER TREAT BRAIN DISEASES

  Avner Schlessinger

  18/02/19

  1 item of Media coverage

  Press/Media